145 related articles for article (PubMed ID: 29729370)
1. Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas.
Bizzi MF; Pinheiro SVB; Bolger GB; Schweizer JROL; Giannetti AV; Dang MN; Ribeiro-Oliveira A; Korbonits M
Mol Cell Endocrinol; 2018 Nov; 476():103-109. PubMed ID: 29729370
[TBL] [Abstract][Full Text] [Related]
2. cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.
Bolger GB; Bizzi MF; Pinheiro SV; Trivellin G; Smoot L; Accavitti MA; Korbonits M; Ribeiro-Oliveira A
Endocr Relat Cancer; 2016 May; 23(5):419-31. PubMed ID: 27267386
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterases and cAMP Pathway in Pituitary Diseases.
Bizzi MF; Bolger GB; Korbonits M; Ribeiro-Oliveira A
Front Endocrinol (Lausanne); 2019; 10():141. PubMed ID: 30941100
[TBL] [Abstract][Full Text] [Related]
4. Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants.
Hernández-Ramírez LC; Trivellin G; Stratakis CA
Horm Metab Res; 2017 Apr; 49(4):286-295. PubMed ID: 28427099
[TBL] [Abstract][Full Text] [Related]
5. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
6. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
7. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
[TBL] [Abstract][Full Text] [Related]
8. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.
Garcia-Rendueles AR; Chenlo M; Oroz-Gonjar F; Solomou A; Mistry A; Barry S; Gaston-Massuet C; Garcia-Lavandeira M; Perez-Romero S; Suarez-Fariña M; Pradilla-Dieste A; Dieguez C; Mehlen P; Korbonits M; Alvarez CV
Oncogene; 2021 Nov; 40(45):6354-6368. PubMed ID: 34588620
[TBL] [Abstract][Full Text] [Related]
9. Impact of AIP and inhibitory G protein alpha 2 proteins on clinical features of sporadic GH-secreting pituitary adenomas.
Ritvonen E; Pitkänen E; Karppinen A; Vehkavaara S; Demir H; Paetau A; Schalin-Jäntti C; Karhu A
Eur J Endocrinol; 2017 Feb; 176(2):243-252. PubMed ID: 27998919
[TBL] [Abstract][Full Text] [Related]
10. Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change.
Mackenzie KF; Topping EC; Bugaj-Gaweda B; Deng C; Cheung YF; Olsen AE; Stockard CR; High Mitchell L; Baillie GS; Grizzle WE; De Vivo M; Houslay MD; Wang D; Bolger GB
Biochem J; 2008 Apr; 411(2):361-9. PubMed ID: 18095939
[TBL] [Abstract][Full Text] [Related]
11. Screening of
Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
[No Abstract] [Full Text] [Related]
12. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
[TBL] [Abstract][Full Text] [Related]
13. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
Oriola J; Lucas T; Halperin I; Mora M; Perales MJ; Alvarez-Escolá C; Paz de MN; Díaz Soto G; Salinas I; Julián MT; Olaizola I; Bernabeu I; Marazuela M; Puig-Domingo M
Eur J Endocrinol; 2013 Jan; 168(1):9-13. PubMed ID: 23038625
[TBL] [Abstract][Full Text] [Related]
15. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
[TBL] [Abstract][Full Text] [Related]
17. Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.
Schernthaner-Reiter MH; Trivellin G; Roetzer T; Hainfellner JA; Starost MF; Stratakis CA
Hum Mol Genet; 2020 Oct; 29(17):2951-2961. PubMed ID: 32821937
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
Chahal HS; Trivellin G; Leontiou CA; Alband N; Fowkes RC; Tahir A; Igreja SC; Chapple JP; Jordan S; Lupp A; Schulz S; Ansorge O; Karavitaki N; Carlsen E; Wass JA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1411-20. PubMed ID: 22659247
[TBL] [Abstract][Full Text] [Related]
19. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
Yarman S; Ogret YD; Oguz FS
Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
